Shattuck Labs Inc
STTK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$558.02M
Close$
$0.47
91.2% downside
Current Fair Value
91.2% downsideOvervalued by 91.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $558.02 Million |
|---|---|
| Enterprise Value | $497.39 Million |
| Earnings per Share | $-0.7 |
| Beta | 1.1 |
| Outstanding Shares | 129,779,297 |
Return
| Return on Equity | -24.90% |
|---|---|
| Return on Assets | -23.82% |
| Return on Invested Capital | -25.69% |
Valuation & Multiples
| P/E Ratio | -10.9 |
|---|---|
| PEG | -50.41 |
| Price to Sales | - |
| Price to Book Ratio | 5.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -9.09 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.12
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.10
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 37.83% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.07%▼ 62.63% |
|---|---|
| Total Invested | $18.23M▼ 96.87% |
| Investors Holding | 23▼ 84.00% |
About Shattuck Labs Inc
59 employees
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck Labs serves customers in the State of Texas.